The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...

Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...

The Trump administration is terminating biodefense research funding for mRNA projects, raising concerns about the nation’s ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter ended ...

The mRNA molecule eventually breaks down in the body. The Cleveland Clinic reports that the risks of mRNA vaccines include pain or swelling at the injection site, fever, fatigue, headaches, muscle ...

Health Secretary Robert F. Kennedy Jr. announced plans Tuesday to cancel $500 million in vaccine development projects. In a ...

Robert F. Kennedy Jr.’s Department of Health and Human Services is terminating 22 mRNA vaccine development investments because “the data show these vaccines fail to protect effectively against upper ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University ...

In an HHS video released yesterday on Fox News, Kennedy said that after consulting with experts from the National Institutes ...